2 Incredible Growth Stocks That Are Screaming Buys for 2024
The new year is here, and for many, it's a fresh opportunity to set financial goals and find fresh stocks to consider adding to a portfolio. The types of stocks you gravitate toward will broadly be informed by your personal risk tolerance levels and interests. Healthcare is one particularly resilient industry to consider as you build out your basket of stocks this year.
Given the wealth of life-saving medicines, medical devices, and other products that healthcare companies produce in mass for a global consumer base, this industry tends to be far more resistant to periods of economic volatility than other spaces. If you're looking to put cash into promising healthcare stocks this month, here are two solid names to consider when you do.
(NYSE: PFE) has gone through a series of monumental changes over the last several years. Now that the feverish need for COVID-19 vaccines and therapies has dwindled compared to even a few years ago, Pfizer is entering another growth phase that has left some investors nonplussed. Shares traded down roughly 40% over the trailing 12 months. From becoming the world's largest producer of penicillin during World War II to its current status as one of the world's largest pharmaceutical companies with revenue streams that span disease areas from oncology to immunology, this is a company that has evolved many times through the years.
Source Fool.com
Pfizer Inc. Stock
With 31 Buy predictions and 4 Sell predictions Pfizer Inc. is one of the favorites of our community.
With a target price of 41 € there is a hugely positive potential of 58.39% for Pfizer Inc. compared to the current price of 25.89 €.
